Mergers and Acquisitions

Allergan Responds to Calls for Shareholder Meeting

Calls for a special meeting of Allergan shareholders to discuss a hostile takeover bid by rival drugmaker Valeant don't change the fact that the buyout offer is "grossly inadequate," Allergan said Wednesday.